Is the use of Bupivacaine hydrochloride 0.5% an effective treatment for the relief of chronic plantar fascial pain?

Completed

• Conditions: Musculoskeletal Diseases: Plantar fasciitis; Musculoskeletal Diseases; Plantar fasciitis

• Registration Number: ISRCTN86484960
• Lead Sponsor: Record Provided by the NHSTCT Register - 2006 Update - Department of Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-09-29
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 80

Inclusion Criteria

The cohort of patients will be recruited from appropriate referrals received from General Practitioners within Primary Care, and Consultants within the UHB Trust for Podiatric assessment and intervention.
Volunteers will be provided with information sheets and informed consent required in writing will be obtained prior to the study. Volunteers will be made aware that their withdrawal form the study at any stage will not adversely affect their future treatment.
Patients over 18 years of age with pain over the medial aspect of the heel, and who fulfill the criteria set down by Saxelby et al (1997).
The Podiatry Department has access to interpreters if there are issues relating to language problems.

Exclusion Criteria

1. Patients with a known sensitivity to local anesthetics
2. Patents with liver disease
3. Patients with kidney disease
4. Patients with broken skin / skin lesions / infection around the injection site
5. Pregnant women
6. Patients on anti coagulation therapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ot provided at time of registration

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration